| Product Code: ETC6665409 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Pyruvate Kinase Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Pyruvate Kinase Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Pyruvate Kinase Market - Industry Life Cycle |
3.4 Canada Pyruvate Kinase Market - Porter's Five Forces |
3.5 Canada Pyruvate Kinase Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Canada Pyruvate Kinase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pyruvate kinase deficiency in Canada |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of pyruvate kinase disorders |
4.2.3 Rising investments in research and development of novel therapies for pyruvate kinase deficiency |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of pyruvate kinase treatments in Canada |
4.3.2 Limited availability of specialized healthcare facilities for pyruvate kinase disorder patients |
5 Canada Pyruvate Kinase Market Trends |
6 Canada Pyruvate Kinase Market, By Types |
6.1 Canada Pyruvate Kinase Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Canada Pyruvate Kinase Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Canada Pyruvate Kinase Market Revenues & Volume, By Pyrukynd (Mitapivat), 2021- 2031F |
6.1.4 Canada Pyruvate Kinase Market Revenues & Volume, By RPL301, 2021- 2031F |
7 Canada Pyruvate Kinase Market Import-Export Trade Statistics |
7.1 Canada Pyruvate Kinase Market Export to Major Countries |
7.2 Canada Pyruvate Kinase Market Imports from Major Countries |
8 Canada Pyruvate Kinase Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for pyruvate kinase deficiency treatments |
8.2 Number of healthcare providers trained in diagnosing and managing pyruvate kinase disorders |
8.3 Funding allocated to research initiatives focused on pyruvate kinase deficiency |
8.4 Adoption rate of new pyruvate kinase therapies in the Canadian market |
9 Canada Pyruvate Kinase Market - Opportunity Assessment |
9.1 Canada Pyruvate Kinase Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Canada Pyruvate Kinase Market - Competitive Landscape |
10.1 Canada Pyruvate Kinase Market Revenue Share, By Companies, 2024 |
10.2 Canada Pyruvate Kinase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |